Quantitative Chimerism
GTR Test Accession: Help GTR000591295.1
CAP
INHERITED DISEASECANCERHEMATOLOGY ... View more
Last updated in GTR: 2020-08-10
Last annual review date for the lab: 2023-07-28 LinkOut
At a Glance
Therapeutic management
Acute lymphoid leukemia
Molecular Genetics - Targeted variant analysis: Multiplex PCR
Not provided
The term chimerism refers to the presence of hematopoietic cells …
Guidance for management
Ordering Information
Offered by: Help
Molecular Genetics and Cytogenetics, Clinical Laboratory Service
View lab's website
Test short name: Help
Chimerism
Specimen Source: Help
Who can order: Help
  • Licensed Physician
Test Order Code: Help
2121
Lab contact: Help
Marcela Lagos, MD, Lab Director
mlagos@med.puc.cl
+56 223548515
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Test service: Help
Identity Testing
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Chromosomal regions/Mitochondria Help
Total chromosomal regions/mitochondria: 1
Chromosomal region/Mitochondrion Associated condition
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument
Targeted variant analysis
Multiplex PCR
AmpFLSTR™ Identifiler™ Direct PCR Amplification Kit
Clinical Information
Test purpose: Help
Therapeutic management
Clinical validity: Help
The term chimerism refers to the presence of hematopoietic cells derived from another individual (in this case the donor) product of a transplantation into a recipient individual (patient). To differentiate between receiver and donor, the same genetic markers, STR, are used as for identification of individuals in general. The method … View more
View citations (1)
  • Hematopoietic chimerism monitoring based on STRs: quantitative platform performance on sequential samples. Kristt D, et al. J Biomol Tech. 2005;16(4):380-91. PMID: 16522860.
Clinical utility: Help
Guidance for management
View citations (1)
  • Hematopoietic chimerism monitoring based on STRs: quantitative platform performance on sequential samples. Kristt D, et al. J Biomol Tech. 2005;16(4):380-91. PMID: 16522860.

Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge? Help
Decline to answer.

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Decline to answer.
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
AmpF/STR Identifiler kit was used for validation. The number of informative loci was evaluated in 19 patients, of whom 8 received transplantation from an unrelated donor and 11 from cord blood. The detection limit of the technique was established between 5% and 95% of chimerism based on the donor. The … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.